GleamWall
中文EN

RGNT REGENTIS BIOMATERIALS LTD. Annual reports only

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1912966 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-384.3%
TTM EPS YoY-1,504.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-337.0%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets37.7%
Debt / equity0.00x
Current ratio—
Interest coverage-88.20x

Cash quality & payout

Operating cash flow / net income0.10x
Accruals ratio-303.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
SG&A expense$6.64M$712,000
Operating income-$6.97M$932,000
Interest expense$79,000$10,000
Pretax income$13.65M-$4.80M
Net income-$13.65M$4.80M
EPS (basic)-24.161.72
EPS (diluted)-24.161.72
Weighted avg. shares (diluted)566,7442.77M
Balance sheet
Cash & equivalents$7.38M—
Total assets$7.62M$482,000
Current liabilities$2.87M$6.49M
Short-term debt$1.20M$573,000
Total liabilities$2.87M$6.49M
Shareholders' equity$4.74M-$41.10M
Shares outstanding5.18M162,198
Cash flow statement
Operating cash flow-$1.38M-$641,000
Financing cash flow$8.52M$525,000
Stock-based compensation$7.04M—

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.